Vanguard Group »

Abcellera Biologics shares owned by Vanguard Group

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $75k 13k 5.71
2023-03-31 $7.5M 989k 7.54
2022-12-31 $9.9M 977k 10.13
2022-06-30 $9.5M 894k 10.65